Colleen Tupper Collegium Pharmaceutical, Inc (COLL) insider trading activity

Colleen Tupper is EVP & Chief Financial Officer of COLLEGIUM PHARMACEUTICAL, INC. Currently has a direct ownership of 156,667 shares of COLL, which is worth approximately $4.65 Million. The most recent transaction as insider was on Mar 21, 2025, when has been sold 6,396 shares (Common Stock) at a price of $30.03 per share, resulting in proceeds of $192,071. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 157K

19.73% 3M change

4.06% 12M change

Total Value Held $4.65 Million

Colleen Tupper Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 21 2025	SELL Open market or private sale	$192,071 $30.03 p/Share	6,396 Reduced 3.92%	156,667 Common Stock
Mar 20 2025	SELL Open market or private sale	$36,180 $30.0 p/Share	1,206 Reduced 0.73%	163,063 Common Stock
Mar 14 2025	SELL Open market or private sale	$29,310 $30.0 p/Share	977 Reduced 0.59%	164,269 Common Stock
Mar 11 2025	SELL Open market or private sale	$313,454 $30.01 p/Share	10,445 Reduced 5.95%	165,246 Common Stock
Mar 07 2025	SELL Open market or private sale	$45,120 $30.0 p/Share	1,504 Reduced 0.85%	175,691 Common Stock
Mar 06 2025	SELL Open market or private sale	$58,470 $30.0 p/Share	1,949 Reduced 1.09%	177,195 Common Stock
Feb 10 2025	SELL Payment of exercise price or tax liability	$928,601 $30.52 p/Share	30,426 Reduced 14.52%	179,144 Common Stock
Feb 10 2025	BUY Grant, award, or other acquisition	-	78,725 Added 27.31%	209,570 Common Stock
May 28 2024	SELL Open market or private sale	$674,279 $34.21 p/Share	19,710 Reduced 13.09%	130,845 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$887,017 $33.7 p/Share	26,321 Reduced 14.88%	150,555 Common Stock
Feb 12 2024	BUY Grant, award, or other acquisition	-	71,456 Added 28.77%	176,876 Common Stock
Mar 15 2023	SELL Open market or private sale	$752,082 $23.77 p/Share	31,640 Reduced 23.08%	105,420 Common Stock
Feb 10 2023	SELL Payment of exercise price or tax liability	$290,344 $26.75 p/Share	10,854 Reduced 7.34%	137,060 Common Stock
Feb 10 2023	BUY Grant, award, or other acquisition	-	57,610 Added 28.03%	147,914 Common Stock
Oct 04 2022	SELL Open market or private sale	$75,473 $17.35 p/Share	4,350 Reduced 4.6%	90,304 Common Stock
Feb 10 2022	SELL Payment of exercise price or tax liability	$71,543 $17.63 p/Share	4,058 Reduced 4.42%	87,654 Common Stock
Feb 10 2022	BUY Grant, award, or other acquisition	-	49,712 Added 35.15%	91,712 Common Stock
May 24 2021	BUY Grant, award, or other acquisition	-	42,000 Added 50.0%	42,000 Common Stock

Colleen Tupper

EVP & Chief Financial Officer

Stoughton, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COLL shares.

Notify only if

Value

Insider Trading

Get notified when an Collegium Pharmaceutical, Inc insider buys or sells COLL shares.

Notify only if

Operation

Value

Type

News

Receive news related to COLLEGIUM PHARMACEUTICAL, INC

Track Activities on COLL

Account